Engineered T cells for cancer therapy

It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline o...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunology, Immunotherapy Vol. 63; no. 9; pp. 969 - 975
Main Authors: June, Carl H., Maus, Marcela V., Plesa, Gabriela, Johnson, Laura A., Zhao, Yangbing, Levine, Bruce L., Grupp, Stephan A., Porter, David L.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.09.2014
Springer Nature B.V
Subjects:
ISSN:0340-7004, 1432-0851, 1432-0851
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0340-7004
1432-0851
1432-0851
DOI:10.1007/s00262-014-1568-1